Compositions and methods for binding lysophosphatidic acid
US9163091B2 · kind B2 · utility
0Cited by
58References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 18, 2009 |
| Grant date | Oct 20, 2015 |
| Priority date | — |
| Expiry date | Mar 18, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q1/6886
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions and methods for making and using anti-LPA agents, for example, monoclonal antibodies, are described. Variable domain and complementarity determining region amino acid sequences of several monoclonal antibodies against LPA are disclosed, as is a consensus anti-LPA monoclonal antibody variable domain sequence.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.